91
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD

, , , &
Pages 163-168 | Published online: 03 Jan 2019

References

  • WangCXuJYangLPrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyLancet2018391101311706171729650248
  • GBD 2015 chronic respiratory disease collaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet Respir Med20175969170628822787
  • FangXWangXBaiCCOPD in China: the burden and importance of proper managementChest2011139492092921467059
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPD Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed November 2011
  • BalkissoonRLommatzschSCarolanBMakeBChronic obstructive pulmonary disease: a concise reviewMed Clin North Am20119561125114122032431
  • CollierTANashABirchHLde LeeuwNHRelative orientation of collagen molecules within a fibril: a homology model for homosapiens type I collagenJ Biomol Struct Dyn Epub2018215
  • BalestriniJLNiklasonLEExtracellular matrix as a driver for lung regenerationAnn Biomed Eng201543356857625344351
  • JonesRLNoblePBElliotJGJamesALAirway remodelling in COPD: It’s not asthma!Respirology20162181347135627381663
  • BanerjeeTMukherjeeSGhoshSClinical significan’ce of markers of collagen metabolism in rheumatic mitral valve diseasePLoS One201493e9052724603967
  • KaiSNomuraAMorishimaYEffect of inhaled steroids on increased collagen synthesis in asthmaRespiration200774215415816465044
  • Al-ShairKKolsumUDockryRMorrisJSinghDVestboJBiomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPDRespir Res201112321208443
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
  • BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
  • UpaguptaCShimboriCAlsilmiRKolbMMatrix abnormalities in pulmonary fibrosisEur Respir Rev20182714818003329950306
  • EriksenEFCharlesPMelsenFMosekildeLRisteliLRisteliJSerum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometryJ Bone Miner Res1993821271328442431
  • Schmidt-ArrasDRose-JohnSIL-6 pathway in the liver: from physiopathology to therapyJ Hepatol20166461403141526867490
  • MauerJDensonJLBrüningJCVersatile functions for IL-6 in metabolism and cancerTrends Immunol20153629210125616716
  • HunterCAJonesSAIL-6 as a keystone cytokine in health and diseaseNat Immunol201516544845725898198
  • AndersenMBPingelJKjærMLangbergHInterleukin-6: a growth factor stimulating collagen synthesis in human tendonJ Appl Physiol201111061549155421350025
  • BeehKMKornmannOBuhlRCulpittSVGiembyczMABarnesPJNeutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4Chest200312341240124712684317
  • ZhangJWuLQuJMJmQInhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 releaseCytokine201154328929521419646
  • IvaskaKKGerdhemPVäänänenHKAkessonKObrantKJBone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 yearsJ Bone Miner Res201025239340319961336
  • LehouckABoonenSDecramerMJanssensWCOPD, bone metabolism, and osteoporosisChest2011139364865721362651
  • InoueDWatanabeROkazakiRCOPD and osteoporosis: links, risks, and treatment challengesInt J Chron Obstruct Pulmon Dis20161163764827099481
  • GarneroPThe utility of biomarkers in osteoporosis managementMol Diagn Ther201721440141828271451
  • ZhaoHHanKLWangZYValue of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumorsMed Sci Monit20111711CR626CR63322037741